Showing results (921-930 of 11,327) with videos related to
Sort By:
Pageof 1,133
Thrombosis and Haemostasis|September 28, 2002
15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockadeS Eligini, C Banfi, M Brambilla, et al.Thrombosis and Haemostasis|October 4, 2002
Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?J P Antovic, R Rafik Hamad, A Antovic, et al.Thrombosis and Haemostasis|August 28, 2002
The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutationsNejma Ameziane, Cendrine Seguin, Delphine Borgel, et al.Thrombosis and Haemostasis|August 28, 2002
Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolismJoel G Ray, Muhammad M Mamdani, Erik L YeoThrombosis and Haemostasis|August 28, 2002
Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse modelMathias Behrmann, John Pasi, Jean-Marie R Saint-Remy, et al.Thrombosis and Haemostasis|August 28, 2002
Importance of N-terminal residues in plasminogen activator inhibitor 1 on its antibody induced latency transitionThu-Hoa Ngo, Yan Zhou, Jean-Marie Stassen, et al.Thrombosis and Haemostasis|August 28, 2002
Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activationKatherine Serrano, Dana V DevineThrombosis and Haemostasis|May 15, 2002
A prospective evaluation of the heat shock protein 70 gene polymorphisms and the risk of strokeRobert Y L Zee, David Bates, Paul M RidkerThrombosis and Haemostasis|May 15, 2002
Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factorL Hilbert, E Fressinaud, A S Ribba, et al.Thrombosis and Haemostasis|May 15, 2002
Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVIDu Xiao-Yan, Edith Magnenat, Timothy N C Wells, et al.Pageof 1,133